Longfellow Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58K | Hold |
3
| – | – | ﹤0.01% | 234 |
|
|
2025
Q1 | $1.9K | Hold |
3
| – | – | ﹤0.01% | 226 |
|
|
2024
Q4 | $2.14K | Hold |
3
| – | – | ﹤0.01% | 228 |
|
|
2024
Q3 | $3.15K | Hold |
3
| – | – | ﹤0.01% | 205 |
|
|
2024
Q2 | $3.15K | Buy |
3
+1
| +50% | +$1.05K | ﹤0.01% | 196 |
|
|
2024
Q1 | $1.93K | Hold |
2
| – | – | ﹤0.01% | 229 |
|
|
2023
Q4 | $1.76K | Hold |
2
| – | – | ﹤0.01% | 207 |
|
|
2023
Q3 | $1.65K | Hold |
2
| – | – | ﹤0.01% | 196 |
|
|
2023
Q2 | $1.44K | Hold |
2
| – | – | ﹤0.01% | 231 |
|
|
2023
Q1 | $1.64K | Hold |
2
| – | – | ﹤0.01% | 225 |
|
|
2022
Q4 | $1.44K | Hold |
2
| – | – | ﹤0.01% | 236 |
|
|
2022
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 318 |
|
|
2022
Q2 | $2K | Buy |
2
+1
| +100% | +$1K | ﹤0.01% | 300 |
|
|
2022
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 381 |
|
|
2021
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 383 |
|
|
2021
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 413 |
|
|
2021
Q2 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 431 |
|